Ipilimumab/nivolumabAdrenal insufficiency: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1973卷 / 1期

关键词：

D O I：

10.1007/s40278-023-45876-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：148 / 148

相关论文

共 50 条

[1] Ipilimumab/nivolumabAdrenal insufficiency: case report
Reactions Weekly, 2020, 1828 (1) : 285 - 285
[2] Ipilimumab/nivolumabAdrenal insufficiency and hypophysitis: case report
Reactions Weekly, 2022, 1920 (1) : 265 - 265
[3] Ipilimumab/nivolumabAdrenal insufficiency and hypophysitis: case report
Reactions Weekly, 2017, 1662 (1) : 213 - 213
[4] Ipilimumab/NivolumabAdrenal Insufficiency and rash: case report
Reactions Weekly, 2024, 2021 (1) : 267 - 267
[5] Ipilimumab/nivolumabAdrenal insufficiency: 2 case reports
Reactions Weekly, 2022, 1899 (1) : 220 - 220
[6] NivolumabAdrenal insufficiency: case report
Reactions Weekly, 2017, 1654 (1) : 250 - 250
[7] NivolumabAdrenal insufficiency: case report
Reactions Weekly, 2019, 1770 (1) : 301 - 301
[8] Ipilimumab/nivolumabAdrenal insufficiency, asthma and chronic obstructive pulmonary disease overlap: case report
Reactions Weekly, 2023, 1978 (1) : 213 - 213
[9] Ipilimumab/nivolumabAdrenal insufficiency and acute renal failure secondary to acute interstitial nephritis: case report
Reactions Weekly, 2020, 1828 (1) : 284 - 284
[10] Ipilimumab/levothyroxine-sodium/nivolumabAdrenal insufficiency
Reactions Weekly, 2023, 1984 (1) : 279 - 279

← 1 2 3 4 5 →